India Insulin Delivery Devices Market Demand, Size and Competitive Analysis | TechSci Research

India Insulin Delivery Devices Market was valued at USD1.06 billion in 2024 and is anticipated to reach USD 1.68 Billion by 2030, with a CAGR of 7.90% during 2025-2030. <table><tr><td>Pages</td><td>85</td></tr> <tr><td>Market Size</td><td>2024: USD 1.06 Billion</td></tr> <tr><td>Forecast Market Size</td><td>2030: USD 1.68 Billion</td></tr> <tr><td>CAGR</td><td>2025-2030: 7.90%</td></tr> <tr><td>Fastest Growing Segment</td><td>Online Pharmacies</td></tr> <tr><td>Largest Market</td><td>North India</td></tr> <tr><td>Key Players</td><td>1.Biocon Limited2.India Medtronic Pvt. Ltd.3.Roche Products (India) Pvt. Ltd.4.Becton Dickinson India Private Limited5.Novo Nordisk India Pvt Ltd6.Sanofi Healthcare India Pvt. Ltd.7.Eli Lilly & Co (India) Pvt. Ltd8.Abbott India Ltd9.B. Braun Medical SE</td></tr> </table>

2024年，印度胰岛素输送设备市场规模达到10.6亿美元，预计到2030年将增长至16.8亿美元，2025年至2030年间的复合年增长率预计为7.90%。

<table>
<tr>
<td>页数</td>
<td>85</td>
</tr>
<tr>
<td>市场规模</td>
<td>2024年：10.6亿美元</td>
</tr>
<tr>
<td>预测市场规模</td>
<td>2030年：16.8亿美元</td>
</tr>
<tr>
<td>复合年增长率（CAGR）</td>
<td>2025-2030年：7.90%</td>
</tr>
<tr>
<td>增长最快的细分市场</td>
<td>在线药店</td>
</tr>
<tr>
<td>最大市场</td>
<td>北印度</td>
</tr>
<tr>
<td>主要参与者</td>
<td>1. Biocon Limited<br>2. India Medtronic Pvt. Ltd.<br>3. Roche Products (India) Pvt. Ltd.<br>4. Becton Dickinson India Private Limited<br>5. Novo Nordisk India Pvt Ltd<br>6. Sanofi Healthcare India Pvt. Ltd.<br>7. Eli Lilly & Co (India) Pvt. Ltd<br>8. Abbott India Ltd<br>9. B. Braun Medical SE</td>
</tr>
</table>